Cargando…
Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
Tumor relapse in triple negative breast cancer patients has been implicated to chemoresistant cancer stem cells (CSCs), which under favorable conditions culminate in tumor re-formation and metastasis. Hence, eradication of CSCs during systemic chemotherapy is imperative. CSCs were sorted using immun...
Autores principales: | Mukherjee, Pritha, Gupta, Arnab, Chattopadhyay, Dhrubajyoti, Chatterji, Urmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569040/ https://www.ncbi.nlm.nih.gov/pubmed/28835684 http://dx.doi.org/10.1038/s41598-017-08971-2 |
Ejemplares similares
-
Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression
por: Bhowal, Ankur, et al.
Publicado: (2017) -
miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression
por: Chatterjee, Abhisek, et al.
Publicado: (2014) -
Self Nano-Emulsifying Curcumin (SNEC30) attenuates arsenic-induced cell death in mice
por: Jamal, Zarqua, et al.
Publicado: (2021) -
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
por: Domenici, Giacomo, et al.
Publicado: (2019) -
Arsenic abrogates the estrogen-signaling pathway in the rat uterus
por: Chatterjee, Aniruddha, et al.
Publicado: (2010)